Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

12.97
Delayed Data
As of Jun 23
 +0.24 / +1.89%
Today’s Change
8.67
Today|||52-Week Range
14.55
+21.21%
Year-to-Date
No recent news for Innoviva Inc.

Today’s Trading

Previous close12.73
Today’s open12.72
Day’s range12.62 - 12.98
Volume1,399,846
Average volume (3 months)1,283,642
Market cap$1.4B
Dividend yield7.72%
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+111.32%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+117.48%
P/E ratio20.3
Price/Sales8.95
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...+0.44+3.64%
EBSEmergent BioSolution...+0.71+2.09%
FOLDAmicus Therapeutics ...+0.35+3.47%
RGENRepligen Corp+4.11+10.25%
Data as of 4:14pm ET, 06/23/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)$0.28
Annual revenue (last year)$147.4M
Annual profit (last year)$59.5M
Net profit margin40.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
Brisbane, California

Forecasts